FDA Inspection 1206882 — Haupt Pharma Latina Srl

Haupt Pharma Latina Srl — FEI 3007687501

The FDA completed an inspection of Haupt Pharma Latina Srl on July 29, 2022 in Latina. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Latina (Italy)

Additional Details

Mutual Recognition Agreement (MRA)